MedTech Innovator Announces the 2024 Mid-Stage Grand Prize & Value Award Winners

MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies, today announced that LATTICE Medical won the 2024 Mid-Stage Grand Prize competition, and Flow Medical won the 2024 Value Award during the MedTech Strategist Innovation Summit in San Diego. 

LATTICE Medical received $200,000 in non-dilutive cash proceeds as the Mid-Stage Grand Prize winner, and Flow Medical received $25,000 in non-dilutive cash as the Value Award winner. 

Now in its second year, the Mid-Stage Competition was established to allow the more mature medtech companies in the accelerator cohort to compete for recognition and cash awards. Each finalist received a prize of $25,000 in non-dilutive funding.

These two competitions conclude the MTI accelerator for 2024, which included 65 cohort companies. Featuring best-in-class emerging medical device, diagnostic, and digital health companies from around the globe, the cohort received unparalleled visibility and access to leading medtech manufacturers, providers, investors, and other industry stakeholders.

During each competition, finalists pitched their technology and answered questions from a panel of industry experts. After the presentations, an audience of industry experts voted in real time to select the winner.

Mid-Stage Grand Prize Competition

This year’s mid-stage competition finalists were selected from among 21 mid-stage companies in the cohort by a vote of MTI’s selection committee. Other finalists include:

• Arsenal Medical (Waltham, Mass.)
• LATTICE Medical (Loos, France) 
• Ozlo (Boston) 
• Somnics Health (Redwood City, Calif.)

“Winning the Mid-Stage Award is both surprising and wonderful. For us, it’s the recognition of seven years of work in breast cancer reconstruction as well as consultation with the American Plastic Surgery Association to bring new options to women and enhance the value of our company,” said Julien Payen, CEO, LATTICE Medical. “It will also elevate the issues in breast reconstruction that we are addressing with our innovative biomaterials and help us gain access to the U.S. market.”

“I’m thrilled to see LATTICE Medical win our Mid-Stage Grand Prize Competition, demonstrating all-around value, momentum, and execution, the criteria our judges considered to select the Mid-Stage finalists,” said Paul Grand, CEO of MedTech Innovator. “The company’s MATTISE 3D-printed, resorbable breast implant is going to change the way reconstructive surgery is done following breast cancer, offering surgeons and their patients a simplified, natural and appropriate breast reconstruction.”

The Mid-Stage Grand Prize finalists were questioned by Abigail Hunter-Syed, Director of Olympus Innovation Ventures, Olympus Corporation, Mirren Mandalia, Senior Director, Global Business Development, Johnson & Johnson MedTech, and Andrea Para, Director of Exploration, Edwards Lifesciences. 

Value Award Competition

The Value Award Competition is the culmination of MTI’s comprehensive Value Program, recognizing the development of outstanding value propositions in each finalist company’s respective clinical areas. 

All participants in the MedTech Innovator accelerator had the opportunity to refine their value propositions over several months with input from MTI’s 27 value coaches.

The value coaches nominated 35 companies for the finals, from which 15 were shortlisted for consideration. Other finalists included: 

• Cellular Vehicles (San Mateo, Calif.)
• CranioSense (Boston), Flow Medical (Chicago) 
• iCE Neurosystems (Washington, D.C.)
• myBiometry (Boston) 

“It was an honor to be on stage with such an impressive group of Value Award finalists, each of whom stands to make an exceptional positive contribution to the healthcare ecosystem,” said Jennifer Fried, CEO and co-founder of Flow Medical. “The first time I went through the MedTech Innovator Value Program with my company Explorer Surgical, it was a software company. Now, working with a traditional medical device company, the considerations are quite different. The value coaches have been instrumental in helping us bridge that gap and chart a course for success.”

“Congratulations to Flow Medical for winning our Value Award, bringing precision medicine to interventional pulmonary embolism treatment, with an all-in-one angiography, infusion, and monitoring catheter designed to enable more personalized treatments, fewer complications and improved outcomes,” said Grand. “We are excited for the entire Flow Medical team, especially CEO and co-founder Jennifer Fried, who is back with her second company in MTI and greatly deserving of this win.”

The Value Award expert judge panelists were Bill Perry, Lead Advisor, American Society of Plastic Surgeons, Tom Shehab, MD, Managing Partner, Arboretum Ventures, and Jason Halac, Senior Director, Dexcom Ventures.